Sleep as a biomarker for depression
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Sleep is a complex biological process that involves cyclic changes of brain activity. The smooth transition between wakefulness and sleep and cyclic succession of sleep stages depend on the function of numerous neurotransmitters that reciprocally influence each other. For this reason sleep is a very sensitive biomarker of brain functioning. This article provides an overview of sleep changes in depression, mechanisms involved in sleep regulation and pathophysiology underlying depression, studies on sleep as a biomarker for depression, effects of antidepressants on sleep EEG, and studies in depression with the use of quantitative sleep EEG analysis. Research on sleep in depression has provided several valuable biomarkers that are related to increased risk for depression, show worsening during depressive episode, and are related to treatment outcome and relapse risk during remission phase. Among many sleep parameters, increased REM density and diminished delta sleep ratio deserve special interest. Sleep studies are also an important research tool for antidepressant drug development. However, due to sensitivity of sleep parameters to pharmacological interventions, the patients have to be investigated before the start of pharmacological treatment or after washout from the antidepressant drug, to obtain reliable data on disease-related biological processes from polysomnography.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothalamic regulation of sleep and circadian rhythms
Saper, C. B., Scammell, T. E., & Lu, J. (2005) · Nature · doi:10.1038/nature04284 · Cited by 2,804 · cited 2×
“2) (Saper et al., 2005).”
BackgroundBaglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.01.011 · Cited by 2,779
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Dement, W., & Kleitman, N. (1957) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(57)90088-3 · Cited by 1,876 · cited 1×
“Usually, there are four to fi ve sleep cycles per night, and a greater amount of deep sleep occurs in the fi rst two sleep cycles, while the proportion of REM sleep increases in the second half of the night (Dement & Kleitman, 1957; Silber et al., 2007).”
Sleep and Psychiatric Disorders: A Meta-analysis
Benca, R. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080059010 · Cited by 1,468 · cited 2×
“Although later studies did not confi rm this suggestion and alterations of REM sleep were described in several other mental disorders (Benca et al., 1992), REM sleep parameters, especially REM density, and altered distribution of delta sleep throughout the sleep period are still regarded as…”
BackgroundA cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
The visual scoring of sleep in adults
Silber, M. H., Ancoli-Israel, S., Bonnet, M. H., Chokroverty, S., Grigg-Damberger, M. M., Hirshkowitz, M., Kapen, S., Keenan, S. A., Kryger, M. H., Penzel, T., et al. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26814 · Cited by 1,064 · cited 1×
“Usually, there are four to fi ve sleep cycles per night, and a greater amount of deep sleep occurs in the fi rst two sleep cycles, while the proportion of REM sleep increases in the second half of the night (Dement & Kleitman, 1957; Silber et al., 2007).”
BackgroundCircadian rhythm disturbances in depression
Germain, A., & Kupfer, D. J. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.964 · Cited by 644 · cited 1×
“Although circadian rhythms are disturbed in many neuropsychiatric states (e.g. psychotic disorders), they seem to be fundamentally disrupted in major depression (Germain & Kupfer, 2008).”
BackgroundREM sleep dysregulation in depression: state of the art
Palagini, L., Baglioni, C., Ciapparelli, A., Gemignani, A., & Riemann, D. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.11.001 · Cited by 513 · cited 1×
“Changes of polysomnographic sleep patterns of depressed patients can be divided into three types (Benca et al., ISSN 0954–0261 print/ISSN 1369–1627 online © 2013 Institute of Psychiatry DOI: 10.3109/09540261.2013.812067 1992; Palagini et al., 2013; Steiger & Kimura, 2010; Wichniak et al., 2012).”
BackgroundInfluentialSleep deprivation in depression: what do we know, where do we go?
Wirz-Justice, A., & Van den Hoofdakker, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00125-0 · Cited by 429
Antidepressants and Sleep: A Qualitative Review of the Literature
Wilson, S., & Argyropoulos, S. (2005) · Drugs · doi:10.2165/00003495-200565070-00003 · Cited by 392
Novel melatonin-based therapies: potential advances in the treatment of major depression
Hickie, I. B., & Rogers, N. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60095-0 · Cited by 334 · cited 1×
“The growing interest in circadian regulation in depression has led also to the development of a new antidepressant, agomelatine, that is a novel non-monoaminergic drug targeting the circadian system in depressed patients (de Bodinat et al., 2010; Hickie & Rogers, 2011; Quera Salva et al., 2011).”
BackgroundDiurnal mood variation in major depressive disorder
Peeters, F., Berkhof, J., Delespaul, P., Rottenberg, J., & Nicolson, N. A. (2006) · Emotion · doi:10.1037/1528-3542.6.3.383 · Cited by 306 · cited 1×
“The core symptom of depression, reduced mood, shows a clear circadian pattern worsening in the early morning hours with noticeable improvement in the evening (Murray, 2007; Peeters et al., 2006).”
BackgroundHypersomnia across mood disorders: A review and synthesis
Kaplan, K. A., & Harvey, A. G. (2009) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2008.09.001 · Cited by 249 · cited 1×
“Hypersomnia is also characteristic for depression in seasonal affective disorder (Kaplan & Harvey, 2009; Abad & Guilleminault, 2005).”
BackgroundThe circadian basis of mood disorders: Recent developments and treatment implications
Monteleone, P., & Maj, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.007 · Cited by 185
Schmid, D. A., Wichniak, A., Uhr, M., Ising, M., Brunner, H., Held, K., Weikel, J. C., Sonntag, A., & Steiger, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300923 · Cited by 165 · cited 3×
“The normalization of HPA axis hyperactivity during antidepressive treatment is related to improvement of sleep in patients with depression (Held et al., 2004; Schmid et al., 2006) and primary insomnia (Rodenbeck et al., 2003).”
BackgroundSelf-citationClinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
Nickel, T., Sonntag, A., Schill, J., Zobel, A. W., Ackl, N., Brunnauer, A., Murck, H., Ising, M., Yassouridis, A., Steiger, A., et al. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00008 · Cited by 152 · cited 1×
“The normalization of the HPA system was suggested as a common mode of action of antidepressants, regardless of their action on the monoaminergic system (Nickel et al., 2003).”
BackgroundSleep and Antidepressant Treatment
Wichniak, A., Wierzbicka, A., & Jernajczyk, W. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523608 · Cited by 142
Self-citationModell, S., Ising, M., Holsboer, F., & Lauer, C. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.004 · Cited by 103 · cited 1×
“It proves that increased REM density can be observed not only in patients with depression, but also in their healthy relatives, in whom it is predictive for the onset of depression (Modell et al., 2005).”
BackgroundRodenbeck, A., Cohrs, S., Jordan, W., Huether, G., R�ther, E., & Hajak, G. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1565-0 · Cited by 103 · cited 1×
“The normalization of HPA axis hyperactivity during antidepressive treatment is related to improvement of sleep in patients with depression (Held et al., 2004; Schmid et al., 2006) and primary insomnia (Rodenbeck et al., 2003).”
BackgroundAbad, V. C., & Guilleminault, C. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.4/vabad · Cited by 102 · cited 3×
“Women who are depressed are more likely to report insomnia than men (Abad & Guilleminault, 2005).”
BackgroundCircadian Rhythms, Melatonin and Depression
A. Quera Salva, M., Hartley, S., Barbot, F., C. Alvarez, J., Lofaso, F., & Guilleminault, C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796197188 · Cited by 100 · cited 2×
“The growing interest in circadian regulation in depression has led also to the development of a new antidepressant, agomelatine, that is a novel non-monoaminergic drug targeting the circadian system in depressed patients (de Bodinat et al., 2010; Hickie & Rogers, 2011; Quera Salva et al., 2011).”
BackgroundResidual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse
Iovieno, N., van Nieuwenhuizen, A., Clain, A., Baer, L., & Nierenberg, A. A. (2011) · Depression and Anxiety · doi:10.1002/da.20768 · Cited by 98 · cited 1×
“Furthermore, in the maintenance phase of treatment with activating antidepressants as many as 30 – 40% of patients may still suffer from insomnia (Iovieno et al., 2011).”
BackgroundImpact of the novel antidepressant agomelatine on disturbed sleep–wake cycles in depressed patients
Quera‐Salva, M., Lemoine, P., & Guilleminault, C. (2010) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1112 · Cited by 92
Modell, S. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00010-1 · Cited by 41
Reboxetine Induces Similar Sleep-EEG Changes Like SSRI’s in Patients with Depression
E., K. H., H., M., K., H., M., Z., & A., S. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-827242 · Cited by 23
Cited by
Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment
Fang, H., Tu, S., Sheng, J., & Shao, A. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14170 · Cited by 1,141
Effects of Antidepressants on Sleep
Wichniak, A., Wierzbicka, A., Walęcka, M., & Jernajczyk, W. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0816-4 · Cited by 557
Self-citationLoeffler, M., Engel, C., Ahnert, P., Alfermann, D., Arelin, K., Baber, R., Beutner, F., Binder, H., Brähler, E., Burkhardt, R., et al. (2015) · BMC Public Health · doi:10.1186/s12889-015-1983-z · Cited by 357
Associations between sex hormones, sleep problems and depression: A systematic review
Morssinkhof, M. W. L., van Wylick, D. W., Priester-Vink, S., van der Werf, Y. D., den Heijer, M., van den Heuvel, O. A., & Broekman, B. F. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.006 · Cited by 257
“After remission of depression, the differences in REM sleep, slow wave sleep and delta sleep ratios tend to reduce (Wichniak et al., 2013).”
BackgroundLow Risk for Switch to Mania during Treatment with Sleep Promoting Antidepressants
Wichniak, A., Jarkiewicz, M., Okruszek, Ł., Wierzbicka, A., Holka-Pokorska, J., & Rybakowski, J. (2015) · Pharmacopsychiatry · doi:10.1055/s-0034-1396802 · Cited by 28
Self-citation
Metadata
- Authors
- Wichniak, A., Wierzbicka, A., & Jernajczyk, W.
- Venue
- International Review of Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2013-10
- Volume
- 25
- Issue
- 5
- Pages
- 632-645
- ISSN
- 0954-0261 (ISSN-L)
- 1369-1627
- OpenAlex
- W2010070030
- Cited by
- 117
- References
- 26
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.